Ponlimsi
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Ponlimsi, covering 2026-01-20 to 2026-01-20. Get the full timeline:
Most recent: EMA Authorised: Ponlimsi (denosumab) — Teva GmbH
1 regulatory and trial event tracked for Ponlimsi, covering 2026-01-20 to 2026-01-20. Get the full timeline:
Most recent: EMA Authorised: Ponlimsi (denosumab) — Teva GmbH